NASDAQ:INMD InMode (INMD) Stock Price, News & Analysis $17.65 +0.19 (+1.09%) (As of 02:38 PM ET) Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipShort InterestTrends Get InMode alerts: Email Address About InMode Stock (NASDAQ:INMD) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get InMode alerts:Sign Up Key Stats Today's Range$17.56▼$18.2350-Day Range$15.43▼$19.0652-Week Range$15.39▼$34.15Volume393,792 shsAverage Volume1.36 million shsMarket Capitalization$1.48 billionP/E Ratio8.36Dividend YieldN/APrice Target$22.40Consensus RatingHold Company OverviewInMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures. It also designs, develops, manufactures, and markets non-invasive medical aesthetic products that target an array of procedures, including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture, and superficial benign vascular and pigmented lesions, as well as hands-free medical aesthetic products that target a range of procedures, such as skin tightening, fat reduction, and muscle stimulation. The company was formerly known as Invasix Ltd. and changed its name to InMode Ltd. in November 2017. InMode Ltd. was incorporated in 2008 and is headquartered in Yokneam, Israel.Read More… Why You Should NOT Trade This Market (Ad)You'll be interested in our 5-Day Options Trading Challenge, starting September 23. So, what makes this different from every other options research you may have seen? Well, for starters... most of them want you to first BUY their service... which is usually thousands of dollars...Just click here to get the full details on the 5-Day Options Trading Challenge, before this offer go InMode Stock Analysis - MarketRank™See Top Rated MarketRank™ StocksOverall MarketRank™: 76th PercentileInMode scored higher than 76% of companies evaluated by MarketBeat, and ranked 307th out of 1,007 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.1 / 5Analyst RatingHold Consensus RatingInMode has received a consensus rating of Hold. The company's average rating score is 2.17, and is based on 1 buy rating, 5 hold ratings, and no sell ratings.Amount of Analyst CoverageInMode has only been the subject of 4 research reports in the past 90 days.Read more about InMode's stock forecast and price target. Earnings and Valuation3.1 / 5Proj. Earnings Growth17.79% Earnings GrowthEarnings for InMode are expected to grow by 17.79% in the coming year, from $1.63 to $1.92 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of InMode is 8.39, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 139.56.Price to Earnings Ratio vs. SectorThe P/E ratio of InMode is 8.39, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 147.29.Price to Book Value per Share RatioInMode has a P/B Ratio of 2.65. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about InMode's valuation and earnings. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares Shorted7.20% of the outstanding shares of InMode have been sold short.Short Interest Ratio / Days to CoverInMode has a short interest ratio ("days to cover") of 4.8.Change versus previous monthShort interest in InMode has recently decreased by 2.89%, indicating that investor sentiment is improving. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldInMode does not currently pay a dividend.Dividend GrowthInMode does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted7.20% of the outstanding shares of InMode have been sold short.Short Interest Ratio / Days to CoverInMode has a short interest ratio ("days to cover") of 4.8.Change versus previous monthShort interest in InMode has recently decreased by 2.89%, indicating that investor sentiment is improving. News and Social Media3.3 / 5News Sentiment0.97 News SentimentInMode has a news sentiment score of 0.97. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.56 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 5 news articles for InMode this week, compared to 6 articles on an average week.Search Interest13 people have searched for INMD on MarketBeat in the last 30 days. This is an increase of 8% compared to the previous 30 days.MarketBeat Follows3 people have added InMode to their MarketBeat watchlist in the last 30 days. This is an increase of 50% compared to the previous 30 days. Company Ownership1.7 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, InMode insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 6.92% of the stock of InMode is held by insiders.Percentage Held by Institutions68.04% of the stock of InMode is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about InMode's insider trading history. Receive INMD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for InMode and its competitors with MarketBeat's FREE daily newsletter. Email Address INMD Stock News HeadlinesInMode Offers High Risk-Reward Opportunity Amid New Products And Rate Cuts (Rating Upgrade)September 19 at 7:14 AM | seekingalpha.comInMode Target of Unusually High Options Trading (NASDAQ:INMD)September 12, 2024 | americanbankingnews.comHave you heard of this 5-Day Challenge yet?You'll be interested in our 5-Day Options Trading Challenge, starting September 23. So, what makes this different from every other options research you may have seen? Well, for starters... most of them want you to first BUY their service... which is usually thousands of dollars...September 19, 2024 | InvestorPlace (Ad)InMode Board Approves Share Repurchase Program - Quick FactsSeptember 10, 2024 | markets.businessinsider.comInMode Announces Share Repurchase Program of Up to 7.68 Million SharesSeptember 10, 2024 | prnewswire.comInMode Stock: An Inverse Bubble Caused By Short-Term TroubleSeptember 6, 2024 | seekingalpha.comInMode to Present at 2024 Baird Global Healthcare ConferenceSeptember 4, 2024 | prnewswire.comInMode (INMD): The Best Middle East and Africa Stocks to Buy According to Analysts?September 2, 2024 | finance.yahoo.comSee More Headlines INMD Stock Analysis - Frequently Asked Questions How have INMD shares performed this year? InMode's stock was trading at $22.24 on January 1st, 2024. Since then, INMD shares have decreased by 20.4% and is now trading at $17.70. View the best growth stocks for 2024 here. How were InMode's earnings last quarter? InMode Ltd. (NASDAQ:INMD) announced its quarterly earnings results on Thursday, August, 1st. The healthcare company reported $0.34 earnings per share for the quarter, missing the consensus estimate of $0.38 by $0.04. The company's revenue was down 24.6% compared to the same quarter last year. When did InMode's stock split? InMode's stock split on Thursday, September 30th 2021. The 2-1 split was announced on Friday, September 17th 2021. The newly minted shares were issued to shareholders after the closing bell on Monday, September 27th 2021. An investor that had 100 shares of stock prior to the split would have 200 shares after the split. Does InMode have any subsidiaries? InMode subsidiaries include Guangzhou InMode Medical Technology Ltd., InMode Asia Limited., InMode India Private Limited, InMode Japan KK, InMode M.D. Ltd., Invasix Corp., Invasix Iberia S.L., Invasix Inc., and Invasix UK Ltd.. When did InMode IPO? InMode (INMD) raised $75 million in an IPO on Thursday, August 8th 2019. The company issued 5,000,000 shares at $14.00-$16.00 per share. Barclays, UBS Investment Bank and Canaccord Genuity served as the underwriters for the IPO and Baird was co-manager. Who are InMode's major shareholders? InMode's top institutional shareholders include Renaissance Technologies LLC (2.46%), Doma Perpetual Capital Management LLC (2.39%), LSV Asset Management (2.21%) and Boston Trust Walden Corp (1.72%). How do I buy shares of InMode? Shares of INMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of InMode own? Based on aggregate information from My MarketBeat watchlists, some other companies that InMode investors own include NVIDIA (NVDA), Alibaba Group (BABA), Salesforce (CRM), Micron Technology (MU), AbbVie (ABBV), Advanced Micro Devices (AMD) and Block (SQ). Company Calendar Last Earnings8/01/2024Today9/19/2024Next Earnings (Estimated)11/07/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Electromedical equipment Sub-IndustryMedical Equipment Current SymbolNASDAQ:INMD CUSIPN/A CIK885988 Webwww.inmodemd.com Phone972-4909-7470FaxN/AEmployees480Year Founded2008Price Target and Rating Average Stock Price Target$22.40 High Stock Price Target$29.00 Low Stock Price Target$16.00 Potential Upside/Downside+27.2%Consensus RatingHold Rating Score (0-4)2.17 Research Coverage6 Analysts Profitability EPS (Most Recent Fiscal Year)$2.11 Trailing P/E Ratio8.35 Forward P/E Ratio10.80 P/E GrowthN/ANet Income$197.92 million Net Margins35.81% Pretax MarginN/A Return on Equity21.00% Return on Assets18.90% Debt Debt-to-Equity RatioN/A Current Ratio8.63 Quick Ratio8.09 Sales & Book Value Annual Sales$416.63 million Price / Sales3.55 Cash Flow$2.30 per share Price / Cash Flow7.64 Book Value$6.68 per share Price / Book2.64Miscellaneous Outstanding Shares83,982,000Free Float78,170,000Market Cap$1.48 billion OptionableOptionable Beta2.17 Social Links The 10 Best AI Stocks to Own in 2024Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free Report This page (NASDAQ:INMD) was last updated on 9/19/2024 by MarketBeat.com Staff From Our PartnersThis diversified cannabis pioneer could make huge moves soonThe cannabis industry seems deeply saturated, so how do you know where to best invest your money? Let’s start ...Greenlane | SponsoredWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredUnlock the Secret to Easy Wins with Iron CondorsDiscover the power of Iron Condor trades – a low-risk, high-reward strategy that allows you to profit consiste...Netpicks | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredProtect Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredKamala Harris and The Woke Progressive NightmareNew research from Jim Rickards - former advisor to the CIA - reveals shocking predictions about an “Election M...Paradigm Press | Sponsored625,000% GainThe recent crypto correction has shaken many investors, causing panic and uncertainty. But while others are fr...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding InMode Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share InMode With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.